ShuYu Civilian Pharmacy Corp., Ltd. (SHE:301017)
China flag China · Delayed Price · Currency is CNY
13.39
+0.09 (0.68%)
At close: Aug 27, 2026

SHE:301017 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
10,65710,2259,4879,1227,7095,286
Other Revenue
102.84102.8483.2669.51114.1335.25
10,76010,3279,5709,1917,8235,322
Revenue Growth
11.70%7.91%4.13%17.49%47.00%14.70%
Cost of Revenue
7,9477,6367,1586,5975,5923,806
Gross Profit
2,8122,6912,4122,5942,2311,515
Selling, General & Admin
2,5562,4652,3922,2591,8121,330
Research & Development
----0.05-
Other Operating Expenses
16.8419.420.1419.8116.5712.47
Operating Expenses
2,5782,4892,4262,3021,8491,342
Operating Income
234.91202.29-13.93291.99381.8173.57
Interest Expense
-126.91-126.91-138.88-118.33-73.43-31.98
Interest & Investment Income
8.5410.2412.2313.7911.1813.56
Currency Exchange Gain (Loss)
000.02-0.01--
Other Non Operating Income (Expenses)
-64.32-37.21-35.58-11.96-11.95-25.34
EBT Excluding Unusual Items
52.2248.41-176.14175.5307.59129.8
Impairment of Goodwill
---48.88---
Gain (Loss) on Sale of Investments
102.53104.58.480.070.1124.82
Gain (Loss) on Sale of Assets
23.4826.7122.6510.252.08-0.71
Legal Settlements
----0.61--9.26
Other Unusual Items
-7.89-7.89-19.45-7.610.775.81
Pretax Income
172.23171.73-213.34177.59320.55150.46
Income Tax Expense
57.9854.82-8.3337.5487.336.14
Earnings From Continuing Operations
114.26116.91-205.01140.05233.24114.32
Minority Interest in Earnings
-10.5-2.6816.2-6.99-3.810.6
Net Income
103.76114.23-188.81133.06229.43114.92
Net Income to Common
103.76114.23-188.81133.06229.43114.92
Net Income Growth
----42.00%99.64%-46.88%
Shares Outstanding (Basic)
421408402403403383
Shares Outstanding (Diluted)
421408402403403383
Shares Change
4.95%1.56%-0.37%0.17%5.07%4.47%
EPS (Basic)
0.250.28-0.470.330.570.30
EPS (Diluted)
0.250.28-0.470.330.570.30
EPS Growth
----42.10%90.00%-49.15%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
589.16630.5315.78-38.6437.99100.92
Free Cash Flow Per Share
1.401.540.79-0.100.090.26
Dividend Per Share
0.0450.045-0.0500.1150.073
Dividend Growth
----56.52%57.53%-33.64%
Gross Margin
26.14%26.06%25.21%28.22%28.52%28.47%
Operating Margin
2.18%1.96%-0.15%3.18%4.88%3.26%
Profit Margin
0.96%1.11%-1.97%1.45%2.93%2.16%
Free Cash Flow Margin
5.48%6.11%3.30%-0.42%0.49%1.90%
EBITDA
291.66253.7461.64359.83440.06219.28
EBITDA Margin
2.71%2.46%0.64%3.91%5.63%4.12%
D&A For EBITDA
56.7551.4575.5767.8358.2645.71
EBIT
234.91202.29-13.93291.99381.8173.57
EBIT Margin
2.18%1.96%-0.14%3.18%4.88%3.26%
Effective Tax Rate
33.66%31.92%-21.14%27.24%24.02%
Revenue as Reported
10,32710,3279,5709,1917,8235,322
Advertising Expenses
-30.5331.841.6436.7929.62